the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males
NCT ID: NCT02573805
Last Updated: 2015-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2015-09-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Early Diagnosis and Warning Role of Erectile Dysfunction
NCT01249703
Raman Spectroscopy Diagnosis of Kidney Diseases
NCT06760845
Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects
NCT04655300
Study the Impact of Hirsutella Sinensis Nutrient Supplements Has on Improving Muscle Health and Metabolism in Elderly
NCT05284149
A Diagnostic Study of Abnormal Acoustic Waves in Modern Pulse in Benign Prostatic Hyperplasia
NCT04802252
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
erectile dysfunction group
International Index of Erectile Function (IIEF-5) questionnaire≥22 Rigiscan test are performed for two nights
Rigiscan test
Rigiscan tests are performed in enrolled subjects for consecutive two nights.
control group
International Index of Erectile Function (IIEF-5) questionnaire\<22 Rigiscan test are performed for two nights
Rigiscan test
Rigiscan tests are performed in enrolled subjects for consecutive two nights.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rigiscan test
Rigiscan tests are performed in enrolled subjects for consecutive two nights.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. age≥20 year;
3. complete the validated International Index of Erectile Function (IIEF-5) questionnaire.
Exclusion Criteria
2. pelvic trauma
3. thyroid diseases
4. metabolic diseases
5. hypogonadism and other hormonal disorders
6. sleep disorders
7. penile deformities
8. taking drugs that may interfere with erectile function.
20 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leilei Zhu
doctor leilei zhu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
l zhu, doctor
Role: PRINCIPAL_INVESTIGATOR
Drum tower Hospital, school of Medicine, Nanjing University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yutian Dai
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NPTR in 2015-09-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.